Zurich Insurance Group (ZURN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Business operating profit reached a record USD 4.8 billion, up 13% year-over-year, with all segments contributing and core EPS rising 11.5% to USD 24.21; net income attributable to shareholders increased 14% to USD 3.5 billion.
Strongest growth observed in Specialty, Middle Market, Life, and Farmers, driven by demand for technology, infrastructure, and protection solutions.
Major acquisitions announced, including Beazley plc and ClearView Wealth Limited, with Beazley expected to close in H2 2026.
Confident in meeting or exceeding 2027 financial targets, supported by robust capital and favorable structural trends.
Financial highlights
Property & Casualty BOP up 16% to USD 2.8 billion; GWP grew 7% to USD 29.9 billion; combined ratio at 92.7%.
Life BOP up 23% to USD 1.3 billion; GWP at USD 19.5 billion; protection premiums up 10%.
Farmers BOP at a record USD 1.2 billion; GWP up 4% to USD 15.6 billion; combined ratio at 82.4%.
Net investment result on Group investments up 35% to USD 4.1 billion; net investment return at 2.4%.
Shareholders’ equity increased to USD 31.3 billion; Swiss Solvency Test ratio at 266%.
Outlook and guidance
Confident in meeting or exceeding all 2027 financial targets, with strong momentum at the midpoint of the three-year plan.
Life BOP for FY 2026 expected to grow by at least 10% year-over-year, above previous guidance.
Beazley acquisition, partly financed by a March 2026 capital raise, expected to close in H2 2026.
Continued focus on higher margin products and resilience in market conditions.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023